ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Carolina J. García García
Matched on ORCID iD 0000-0001-8330-1746; OpenAlex author ID A5040643325. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2021: 2 papers · 2022: 2 papers
Papers 4
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1053/j.gastro.2022.02.024↗
- Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. Co-author DOI 10.1186/s12885-022-09255-3↗
- Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.adro.2020.11.006↗
- ADAM10 Evens Out the Double-Edged Sword of Radiotherapy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-21-0519↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cullen M. Taniguchi · 4 shared papers, 2021–2022 · strength 0.59
- Paper ADAM10 Evens Out the Double-Edged Sword of Radiotherapy in Pancreatic Cancer. DOI 10.1158/0008-5472.can-21-0519↗
- Paper Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. DOI 10.1186/s12885-022-09255-3↗
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Joseph Abi Jaoude · 3 shared papers, 2021–2022 · strength 0.47
- Paper ADAM10 Evens Out the Double-Edged Sword of Radiotherapy in Pancreatic Cancer. DOI 10.1158/0008-5472.can-21-0519↗
- Paper Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. DOI 10.1186/s12885-022-09255-3↗
- Paper Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pa… DOI 10.1016/j.adro.2020.11.006↗
- Abagail M. Delahoussaye · 2 shared papers, 2022 · strength 0.26
- Tara N. Fujimoto · 2 shared papers, 2022 · strength 0.26
- Nicholas D. Nguyen · 2 shared papers, 2021–2022 · strength 0.22
- Daniel Lin · 2 shared papers, 2021–2022 · strength 0.22
- Emily G. Caggiano · 1 shared paper, 2022 · strength 0.12
- Natividad Roberto Fuentes · 1 shared paper, 2022 · strength 0.12
- Meifang Yu · 1 shared paper, 2022 · strength 0.12
- Maria E. Monberg · 1 shared paper, 2022 · strength 0.12
- Jaewon James Lee · 1 shared paper, 2022 · strength 0.12
- Jun Zhao · 1 shared paper, 2022 · strength 0.12
- Vincent Bernard · 1 shared paper, 2022 · strength 0.12
- Anirban Maitra · 1 shared paper, 2022 · strength 0.12
- Dieter Saur · 1 shared paper, 2022 · strength 0.12
- Albert C. Koong · 1 shared paper, 2021 · strength 0.10
- Irina Mihaela Cazacu · 1 shared paper, 2021 · strength 0.10
- Ramez Kouzy · 1 shared paper, 2021 · strength 0.10
- Grace L. Smith · 1 shared paper, 2021 · strength 0.10
- Joseph M. Herman · 1 shared paper, 2021 · strength 0.10
- Shalini Moningi · 1 shared paper, 2021 · strength 0.10
- Eugene Jon Koay · 1 shared paper, 2021 · strength 0.10
- Manoop S. Bhutani · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.